Cova Capital Parters

Member of FINRA and SIPC

Team

Edward T. Gibstein

CEO

Edward Gibstein has been licensed in the financial industry since 1982. In 1989, Mr. Gibstein began his Wall Street career with Lehman Brothers. After achieving the title of Senior Vice President and member of both the President's and Chairman's Council, Mr. Gibstein then moved to Prudential Securities. In 1996, he formed Taylor Stuart Financial (TSFI), where he served as Chairman and CEO. As Chairman, he guided all aspects of the firm, including Investment Banking, Retail Brokerage, Proprietary Trading and Market Making. As CEO, Mr. Gibstein focused much of his efforts on Investment Banking, and was successful in raising significant funds for both private and publicly listed companies.

In 2010, Mr. Gibstein joined Bannockburn Partners, LLC, and subsequently purchased the firm in 2012. Bannockburn Partners, LLC changed its name to COVA Capital Partners, LLC, later the same year.

Mr. Gibstein is active in his community. He sits on the Commerce and Industry Committee of North Shore LIJ Health System, one of the country's largest; on the Advisory Board of Rock and Wrap It Up, a charity fighting hunger and poverty in the United States; and is a member of the Executive Board of the Long Island Golf Association. He has also served on the Board of Directors of Engineers Country Club, where he has been a member for over 20 years.

Mr. Gibstein is an accomplished amateur golfer, and twice was named the Long Island Golf Association's Player of The Year. He enjoys skiing, traveling and spending time with his wife and two children.

Mr. Gibstein is a graduate of New York University and holds a FINRA Series 7, 63, 66, 79, and a Series 24 Securities Principal, License. Mr. Gibstein has also worked in the Insurance industry for a number of years, and currently holds Broker licenses for Life, Accident, and Health Insurance, as well as a Property and Casualty Insurance.

Email: egibstein@covacp.com


William John Odenthal

Managing Director Investment Banking, Capital Markets

William Odenthal has over 30 years of capital markets and equities banking experience. He currently is Principal and Head of Investment Banking for Alere Financial Partners, LLC., exploring innovative, small capitalization public corporations, primarily in the biomedical sector; providing comprehensive banking and advisory initiatives.

In June of 2013, William Odenthal founded Alere Financial Partners, LLC., as a division of Summer Street Research Partners. During his tenure at Summer Street he served as Director of Investment Banking, managing all aspects of equities banking deals for Alere Financial Partners, LLC. Over his eighteen month tenure at Summer Street, Mr. Odenthal oversaw, and was the lead investment banker on over 40mm dollars of unregistered security placements to institutional investors.

Prior to Summer Street Research Partners, Mr. Odenthal instituted the advisory business at The Benchmark Company. As a leader of Capital Markets at Benchmark from March of 2007 until June 2013, he orchestrated dozens of non deal road shows and attended multiple investment conferences.

Additionally, Mr. Odenthal served as a Principal and Chief Operating Officer of Weatherly Securities for over five years supervising over 160 employees in three branch offices. Over his tenure at Weatherly he was the President and Chief Operating Officer and acted as a principal of the firm.

Principal/Supervisory Exams

General Securities Principal Examination - Series 24
General Securities Representative Examination - Series 7
Uniform Securities Agent State Law Examination - Series 63
Investment Banking Representative Qualification Examination - Series 79

Phone: 917-747-4762
Email: wodenthal@alerefinancial.com


Adam R. Levy

Managing Director Investment Banking

In 1985 founded Warlock Records, which signed, recorded and promoted approximately 20 gold and platinum albums by artists including Christina Aguilera, Trick Daddy and Dance mix USA. Through Warlock, Mr. Levy acquired and restructured 16 financially distressed record labels. In 1994 and 1996, Warlock was named independent label of the year. This culminated in Warlock's sale in 2009, which presented the time and capital to purse diverse business interests. In 2013, co-founded Alere Financial Partners, where he works full-time to enhance value for Management and investors. Mr. Levy is expert in corporate debt work-outs and cash flow restructuring. He serves as consultant and legal advisor in matters of intellectual property and contracts. Cooperatively, Mr. Levy directly assists Management to assess and implement productive structural and operational change.

Principal/Supervisory Exams

General Securities Principal Examination - Series 24
General Securities Representative Examination - Series 7
Uniform Securities Agent State Law Examination - Series 63
Investment Banking Representative Qualification Examination - Series 79

Phone: 917-378-7432
Email: alevy@alerefinancial.com


Kevin Cody

Institutional Sales Capital Markets

Mr. Cody brings over 20 years of financial markets experience to the Alere Financial team.  In the early stages of his career Mr. Cody worked on equity structured products sales for institutional clients in the New York, Tokyo and Hong Kong markets. More recently, Mr. Cody brought that institutional experience to build an alternative investment platform for high net worth and family office investors. Over the past 5 years he has narrowed his focus on medical technology companies with strong management teams that require purposeful funding.  The collaborative effort of the Alere Financial Alternative Investment Platform will provide multiple funding channels for companies at every stage of their development. Mr. Cody holds a Bachelor’s of Science Degree from Marist College in Poughkeepsie NY.

FINRA Registered Representative

General Securities Representative Examination - Series 7
Uniform Securities Agent State Law Examination - Series 63

Phone: 917-566-3322
Email: KCody@alerefinancial.com


Curtis Leahy

Institutional Sales Investment Banking

Curtis Leahy is an Investment Banker/Institutional Sales Representative for COVA Capital Partners, LLC. Mr. Leahy holds Series 7, 63, and 79 licenses. Mr. Leahy has over sixteen years of experience in institutional sales and trading which began at Meridian Capital, an institutional investment banking firm in Newport Beach, California that was acquired by E-Offering in 2000 and then subsequently acquired by Wit Capital (later Wit Soundview). Mr. Leahy was most recently Director of Institutional Sales at Antaeus Capital for five years. Prior to that, he was a leading institutional sales rep at Grant Bettingen, Inc., where he was the firm's top producer for several years. Mr. Leahy provides a unique and extensive knowledge in life sciences, biotech and medical devices having spent the 13 years prior in the Biotechnology/Pharmaceutical industry. Mr. Leahy's expertise in life sciences has proven to be a valuable resource to both the firm and his clients.

In 1990, Mr. Leahy joined Scripps Laboratories in San Diego, California as Director of Business Development. While at Scripps Laboratories, Mr. Leahy was responsible for the strategic and long term growth of the organization, focusing on new business by way of technology licensing, technology assessment, technology acquisition and technology transfer. In 1987, Mr. Leahy joined what was at the time a start up pharmaceutical company called IDEC Pharmaceuticals (now Biogen/IDEC, Ticker: BIIB) and established the company's Autoimmune Disease program focusing on HIV. While at IDEC, Mr. Leahy's autoimmune disease research was presented at the First and Second International Congress on AIDS and received Honorable Mention. Mr. Leahy began his career in life sciences in 1982 at Hybritech, Inc., one of the first biotechnology companies in San Diego, California, working in the assay development lab until the company was sold to Eli Lilly in 1985. Thereafter, Mr. Leahy became product facilitator for Eli Lilly, coordinating manufacturing and operations with the Lilly headquarters in Indianapolis.

The following is a partial list of life sciences and high technology transactions completed by Curtis Leahy: Arena Pharmaceuticals, SpiralFrog, China TransInfo, Halozyme, Axesstel, V.Computer Immune Systems, Adamis Pharmaceuticals, Taser, Javelin Systems, InfaCare Pharmaceuticals, Apthera, Inc. and Brooke Corporation totaling over $250mm in private placement capital over the past decade.

Phone: 858-663-6906
Email: cleahy@covacp.com


Cody Corrubia

Cody has been a licensed Securities Broker and currently maintains the following licenses 7, 55, 63, and 79. Cody has been instrumental in funding both equity and debt transactions in various sectors and commodities. He has worked as a market maker, institutional sales, investment banking, and M&A for the last 20 years.


Providing professional corporate finance consulting and funding through institutional and accredited investors and lenders.